MN-166 (ibudilast) is an orally administered small molecules designed to modulate neuroinflammation and oxidative stress pathways implicated in ALS progression. The COMBAT-ALS study is a randomized, ...
Threat-Informed Defense shifts cybersecurity from reactive to proactive using MITRE ATT&CK, enabling 85% ransomware detection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback